• INFECTIONS AND ANTI – INFECTIVES
    • SEPSIS – A CASE BASED APPROACH
    • SEPSIS GUIDELINES 2021- WHAT’S NEW?
    • EMPERIC ANTIBOITIC APPROACH AND ANTIBOITIC DEESCALTION IN ICU
    • COMMUNITY ACUIRED PNEUMONIA
    • INVASIVE FUNGAL INFECTIONS – A CASE BASED APPROACH
    • NEWER ANTIBIOTICS IN THE PIPELINE
    • MDR GRAM NEGATIVES IN ICU: BASICS AND BEYOND
    • DIFFERENTIAL USAGE OF CARBAPENAMS: CURRENT EVIDENCE
    • APPROACH TO TROPICAL INFECTIONS IN ICU
    • PK - PD OF ANTIBIOTICS IN CRITICALLY ILL PATIENTS
    • INTERPRETATION OF CULTURE SENSITIVITY REPORT: -MIC, BPC, MPC WHAT TO SEE AT THE BEDSIDE?
    • RAPID DIAGNOSTICS AND THERAPEUTIC DRUG MONITORING IN ICU: IS IT THE FUTURE?
    • TREATING HIV PATIENT: ICU PERSPECTIVE
    • INFECTION CONTROL POLICIES IN ICU: -CARING OF LINES, DRAINS AND PIPES, BIOMEDICAL WASTE MANAGEMENT, TRANSMISSION SPECIFIC ISOLATION PRECAUTIONS
    • IMMUNOMODULATION IN ICU WHAT IS THE EVIDENCE: - ULINASTATIN, METHYLENE BLUE, SEPSIVAC, THYMOCIN ALPHA, INTERFERON ALPHA MARIK’S PROTOCOL
  • HEAMODYNAMIC MONITORING
    • PRESSURE BASED INDECES / STATIC PARAMETERS-CVP, PAOP AND ARTERIAL LINE
    • CASE BASED DISCUSSION-VOLUME BASED INDECES / DYNAMIC PARAMETERS-PPV, SVV, SPV
    • CARDIAC OUTPUT MONITORING AN OVERVIEW
    • CARDIOGENIC SHOCK-CASE BASED APPROACH
    • OBSTRUCTIVE SHOCK-CASE BASED APPROACH
    • CASE BASED DISCUSSION- FLUID RESPONSIVENESS AND ADVANCED HEMODYNAMIC MONITORING: FLOW TRAC / VOLUME VIEW / PLR
  • RESUSCITATION AND DERESUSCITATION
    • PCO2 GAP - PRACTICAL UTILITY AT THE BEDSIDE.
    • LACTATE IN NORMOTENSIVE PATIENTS: ITS CLINICAL RELEVANCE.
    • MICROCIRCULATORY ASSESSMENT IN ICU: WHERE WE ARE TODAY?
    • DE-RESUSCITATION IN ICU PATIENTS: WHEN AND WHICH PATIENTS TO BE INITIATED?
  • CARDIAC CRITICAL CARE
    • TREATING ATRIAL FIBRILLATION IN ICU
    • ACUTE CORONARY SYNDROME
    • ACUTE PULMONARY EMBOLISM
    • UNDERSTANDING DIASTOLIC DYSFUNCTION: CASE BASED APPROACH
    • NEWER DRUGS TO TREAT HEART FAILURE
    • MANAGEMENT OF SEPSIS INDUCED CARDIOMYOPATHY: CURRENT EVIDENCE
    • RIGHT HEART FAILURE IN ICU: A PROTOCOLIZED APPROACH
    • MECHANICAL CIRCULATORY SUPPORT DEVICES IN ICU (IABP, LVAD, IMPELLA): AN OVERVIEW
    • ECMO BASICS
    • CLS/BLS
    • POST CARDIAC ARREST CARE
    • PACEMAKER IN ICU
  • ARDS
    • ARDS GENERAL AND VENTILATORY ASPECTS
    • LANDMARK TRAILS IN ARDS
    • UNDERSTANDING ARDS: CASE BASED APPROACH
  • RESPIRATORY CRITICAL CARE
    • VENTILATOR ASSOCIATED PNEUMONIA
    • COPD – ICU MANAGEMENT
    • BRONCHIAL ASTHMA – ICU MANAGEMENT
    • AN EVIDENCE BASED MANAGEMENT OF COVID 19 IN ICU: AN OVERVIEW OF EVIDENCE TILL NOW
    • SYSTEMATIC APPROACH TO AIRWAY MANAGEMENT IN ICU: IS IT A DIFFERENT BALL GAME?
  • MECHANICAL VENTILATION
    • NON-INVASIVE VENTILATION: CURRENT EVIDENCE
    • HIGH FLOW NASAL CANULA: CURRENT EVIDENCE
    • BASICS OF VENTILATOR GRAPHICS
    • ADVANCED MODES OF MECHANICAL VENTILATION AN OVERVIEW
    • WEANING FAILURE AND DIFFICULTY IN WEANING
    • DIAPHRAGM PROTECTIVE VENTILATION: WHAT IT IS EXACTLY?
    • PATIENT SELF INFLICTED LUNG INJURY: UNDERSTANDING THE NEW CONCEPT.
    • LUNG STRESS AND STRAIN IN MECHANICAL VENTILATION.
  • FLUIDS, ELECTROLYTES & BLOOD
    • IV FLUID THERAPY IN ICU – CURRENT EVIDENCE
    • ALBUMIN IN ICU: WHEN, HOW MUCH AND WHICH PATIENTS?
    • APROACH TO HYPONATREMIA
    • APPROACH TO HYPERNATREMIA
    • MASSIVE TRANSFUSION PROTOCOL AND DAMAGE CONTROLLED RESUSCITATAION
    • AN APPROACH TO ARTERIAL BLOOD GAS ANALYSIS
  • ENDOCRINE AND NUTRITION
    • AN APPROACH TO ENTERAL NUTRITION IN ICU
    • DISEASE SPECIFIC NUTRITION
    • PHARMACO-NUTRITION
    • REFEEDING SYNDROME
    • DIABETIC EMERGENCIES IN ICU: DKA, HHS & HYPOGLYCEAMIA
  • GUT, LIVER AND PANCREAS
    • CLOSTRIDIUM DIFFICILE DIARRHEA
    • SEVERE ACUTE PANCREATITIS
    • ACUTE FULMINANT LIVER FAILRE
    • ABDOMINAL COMPARTMENT SYNDROME
    • ICU MANAGEMENT OF UPPER GASTROINTESTINAL BLEED
    • ICU MANAGEMENT OF LOWER GASTROINTESTINAL BLEED
  • NEURO CRITICAL CARE
    • SUB ARACHNOID BLEED
    • MANAGING STROKE: ICU PERSPECTIVE
    • GB SYNDROME
    • MYASTHENIA GRAVIS
    • ICU ACQUIRED WEAKNESS
    • TREATING MENINGITIS: ICU PERSPECTIVES
    • A STEPWISE APPROACH TO REFRACTORY STATUS EPILEPTICUS
    • AUTO IMMUNE ENCEPHALITIS: ICU PERSPECTIVE
    • ENCEPHALOPATHY IN ICU: METABOLIC
    • ENCEPHALOPATHY IN ICU: SEPTIC
  • ONCO CRITICAL CARE AND HEAMATOLOGICAL ISSUES
    • TUMOUR LYSIS SYNDROME
    • HYPERLEUCOCYTOSIS SYNDROME
    • APPROACH TO FEBRILE NEUTROPENIA
    • OVERVIEW ON MANAGEMENT OF POST-TRANSPLANT PATIENT IN ICU
    • THROMBOTIC MICRO ANGIOPATHY IN ICU: - TTP
    • THROMBOTIC MICRO ANGIOPATHY IN ICU: - HUS
    • MACROPHAGE ACTIVATION SYNDROME / HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) SYNDROME IN ICU
  • TRAUMA/BURNS/SNAKE BITE/TOXOCOLOGY
    • GENERAL VIEW ON ADVANCED TRAUMA LIFE SUPPORT (ATLS)
    • ABDOMINAL TRAUMA
    • TRAUMATIC BRAIN INJURY
    • AN EVIDENCE-BASED MANAGEMENT OF BURNS PATIENT IN ICU
    • ICU MANAGEMENT OF PATIENT WITH SNAKE BITE
    • TOXICOLOGY GENERAL APPROACH
  • PERI-OPERATIVE CRITICAL CARE
    • MANAGING CRITICALLY ILL POST SURGICAL PATIENT SEPSIS: A PRACTICAL CASE BASED APPROACH
    • MANAGING POST OPERATIVE MYOCARDIAL INFARCTION: PRACTICAL CONSIDERARTION
    • MANAGING POSTOPERATIVE PULMONARY EMBOLISM: PRACTICAL CONSIDERATIONS
    • PERI OPERATIVE ARRYTHMIA
  • NEPHRO CRITICAL CARE
    • ACUTE KIDNEY INJURY
    • PRINCIPLES OF RENAL REPLACEMENT THERAPY
    • ROLE OF EXTRACORPOREAL FILTERS (CYTOSORB, OXARIS, TORAYMYXIN AND LPS ADSORBER) IN CRITICALLY ILL PATIENTS: WHERE WE ARE TODAY?
    • DIURETICS IN ICU: WHEN, HOW MUCH AND WHICH PATIENTS?
    • THERAPEUTIC PLASM EXCHANGE IN ICU: WHAT IS THE EVIDENCE?
  • ORGAN CROSSTALKS IN ICU
    • Organ crosstalk in ICU patients: -Cardiorenal syndrome
    • Organ crosstalk in ICU patients: - Pulmonary renal syndrome
    • Organ crosstalk in ICU patients: - Hepatorenal syndrome
  • PRACTICAL POINTS TO REMEMBER ON ANTIBIOTICS, ANTIVIRALS AND ANTIFUNGALS: AN INTENSIVIST PERSPECTIVE
    • AN OVERVIEW ON DOXYCYCLINE, TIGECYCLINE AND MINOCYCLINE
    • AN OVERVIEW ON GLYCOPEPTIDES IN ICU: VANCOMYCIN AND TEICOPLANIN
    • AN OVERVIEW ON LINEZOLID
    • AN OVERVIEW ON CLINDAMYCIN
    • AN OVERVIEW ON DAPTOMYCIN
    • AN OVERVIEW ON FOSFOMYCIN USE IN ICU
    • AN OVERVIEW ON LEVONADIFLOXACIN: A NOVEL ANTI-MRSA ANTIBIOTIC
    • AN OVERVIEW ON POLYMYXINS IN ICU
    • AN OVERVIEW ON ARBEKACIN
    • AN OVERVIEW ON ROLE OF CEFTRIAXONE SULBACTAM DISODIUM EDETATE IN THE ICU
    • AN OVERVIEW ON CEFTAROLINE
    • AN OVERVIEW ON CEFTAZIDIME AVIBACTAM AND AZTREONAM AVIBACTAM
    • AN OVERVIEW ON AZTREONAM AVIBACTAM
    • AN OVERVIEW ON HIGH DOSE SULBACTAM
    • AN OVERVIEW ON ECHINOCANDINS: ANIDULAFUNGIN, MICAFUNGIN AND CASPOFUNGIN
    • AN OVERVIEW ON ERTAPENEM
    • AN OVERVIEW ON FAROPENEM
    • AN OVERVIEW ON VORICONAZOLE
    • AN OVERVIEW ON ISAVUCONAZOLE
    • AN OVERVIEW ON POSACONAZOLE
    • AN OVERVIEW ON AMPHOTERICIN -B
    • AN OVERVIEW ON ANTIVIRALS: - ACYCLOVIR, GANCICLOVIR, VALGANCYCLOVIR AND FOSCARNET
  • MISCELLANEOUS
    • MANAGEMENT OF CRITICALLY ILL PREGNANT PATIENT
    • MANAGEMENT OF COMPLICATED SKIN-SOFT TISSUE INFECTIONS IN ICU
    • NEWER ANTI COAGULANTS AND DVT
    • STEROIDS IN ICU: WHEN, HOW MUCH AND WHICH PATIENTS?
    • IVIG IN ICU: WHEN, HOW MUCH AND WHICH PATIENTS?
    • BUNDLE CARE APPROACH IN ICU
    • SCORING SYSTEM IN ICU
    • HOW TO DO CRITICAL APPRAISAL OF PAPER?
    • END OF LIFE CARE PRINCIPLES
    • BRAIN DEATH DECLARATION AND ORGAN PRESERVATION
    • IMAGING IN ICU
    • ICU ORGANISATION AND STRUCTURE: WHAT WE NEED TO UNDERSTAND?
    • CRITICAL APPRAISAL OF LANDMARK TRAILS IN ICU - LAST FIVE YEARS

Copyright © 2024 Critical Care Medicine. All Rights Reserved.    Terms & Conditions